The Latest Breaking News from FDA

Robert F. Kennedy Jr. stated in an interview that he believes entire departments of the Food and Drug Administration (FDA) are unnecessary and should be dissolved.

Biotech stocks are surging as groundbreaking neuroscience and gene therapy innovations take center stage. Amid this backdrop, investors might consider adding fundamentally strong biotech stocks like Regeneron Pharmaceuticals (REGN), Biogen (BIIB), and Gilead Sciences (GILD) to their portfolio for an impactful investment. Continue reading….

Pain-sensing neurons exchange signals with immune cells that drive endometriosis, sparking the pain associated with the condition, new research suggests.

President-elect Donald Trump has repeatedly said he would put RFK Jr. in charge of federal health agencies

Biotech stocks jumped early Wednesday on hopes for more innovation and dealmaking after Donald Trump clinched his second presidency.

The cheeses had “limited regional distribution in the United States,” per an announcement posted by the FDA

President-elect chooses Federal Communications Commission Commissioner Brendan Carr to lead body charged with regulating US media

“I’m surprised at myself at this point," LeBron James says about his stamina on the court.

Vertex beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.

Kamala Harris says vaccine skeptic is ‘exact last person’ who should be setting policy for families and children

With increasing chronic diseases, demand for personalized medicines, and adoption of AI, the biotech market is booming. Therefore, it could be wise to invest in solid biotech stocks Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD) for substantial returns. Read more.